This content is restricted to site members. If you are an existing user, please log in. New users may register below.
SEBI probes suspected insider trading, disclosure lapses at Fortis Healthcare
(G.N.S) DT.22 New Delhi Regulator Sebi is probing suspected insider trading by some institutional investors and other regulatory lapses at Fortis HealthcareNSE -2.16 % amid a takeover battle and boardroom upheaval at the hospital chain, officials said. Apart from the SEBI probe that also includes investigation into suspected disclosure lapses,